B. Schock

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

T. Flynn, R. Bosch, E. Adams, 2009, Vaccine.

A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection

D. Katzenstein, M. Jacobson, R. Pollard, 2002, AIDS.

A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3).

M. Lederman, R. Bosch, C. Shikuma, 2003, Journal of acquired immune deficiency syndromes.

Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.

J. Fahey, D. Mildvan, S. Grossberg, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

R. Schooley, M. Lederman, D. Kuritzkes, 2010, The Journal of infectious diseases.

Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.

D. Haas, A. Landay, D. Mildvan, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248)

M. Lederman, R. Gelman, K. Squires, 2004, Journal of acquired immune deficiency syndromes.

Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.

M. Lederman, D. Kuritzkes, H. Kessler, 2003, The Journal of infectious diseases.

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation.

M. Lederman, D. Mildvan, R. Coombs, 2002 .

Placebo‐Controlled Trial of Cyclosporin‐A in HIV‐1 Disease: Implications for Solid Organ Transplantation

M. Lederman, D. Mildvan, R. Coombs, 2002, Journal of acquired immune deficiency syndromes.